Muro K - Search Results

1

[Chemoradiotherapy for esophageal cancer].

Takahari D, Muro K. Takahari D, et al. Among authors: muro k. Nihon Shokakibyo Gakkai Zasshi. 2009 Jun;106(6):771-8. Nihon Shokakibyo Gakkai Zasshi. 2009. PMID: 19498307 Review. Japanese. No abstract available.

2

Concurrent chemoradiotherapy for esophageal carcinoma patients with malignant fistulae.

Muto M, Ohtsu A, Miyamoto S, Muro K, Boku N, Ishikura S, Satake M, Ogino T, Tajiri H, Yoshida S. Muto M, et al. Among authors: muro k. Cancer. 1999 Oct 15;86(8):1406-13. Cancer. 1999. PMID: 10526266

3

A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer.

Muro K, Hamaguchi T, Ohtsu A, Boku N, Chin K, Hyodo I, Fujita H, Takiyama W, Ohtsu T. Muro K, et al. Ann Oncol. 2004 Jun;15(6):955-9. doi: 10.1093/annonc/mdh231. Ann Oncol. 2004. PMID: 15151954 Free article. Clinical Trial.

4

[Chemoradiotherapy].

Muro K. Muro K. Nihon Geka Gakkai Zasshi. 2008 Jan;109(1):15-20. Nihon Geka Gakkai Zasshi. 2008. PMID: 18320805 Review. Japanese.

5

Chemosensitivity of patients with recurrent esophageal cancer receiving perioperative chemotherapy.

Takashima A, Shirao K, Hirashima Y, Takahari D, Okita N, Akatsuka S, Nakajima TE, Matsubara J, Yasui H, Asakawa T, Kato K, Hamguchi T, Muro K, Yamada Y, Shimada Y. Takashima A, et al. Among authors: muro k. Dis Esophagus. 2008;21(7):607-11. doi: 10.1111/j.1442-2050.2008.00821.x. Epub 2008 Apr 22. Dis Esophagus. 2008. PMID: 18430178

6

Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1.

Shitara K, Muro K, Ura T, Takahari D, Yokota T, Sawaki A, Kawai H, Ito S, Yamamura Y. Shitara K, et al. Among authors: muro k. Jpn J Clin Oncol. 2008 Nov;38(11):786-9. doi: 10.1093/jjco/hyn096. Epub 2008 Sep 26. Jpn J Clin Oncol. 2008. PMID: 18820010

7

A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.

Nakajima TE, Ura T, Ito Y, Kato K, Minashi K, Nihei K, Hironaka S, Boku N, Kagami Y, Muro K. Nakajima TE, et al. Among authors: muro k. Jpn J Clin Oncol. 2009 Jan;39(1):37-42. doi: 10.1093/jjco/hyn125. Jpn J Clin Oncol. 2009. PMID: 19103671 Clinical Trial.

8

Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX.

Shitara K, Matsuo K, Takahari D, Yokota T, Inaba Y, Yamaura H, Sato Y, Najima M, Ura T, Muro K. Shitara K, et al. Among authors: muro k. Eur J Cancer. 2009 Jul;45(10):1757-63. doi: 10.1016/j.ejca.2009.01.019. Epub 2009 Feb 11. Eur J Cancer. 2009. PMID: 19217278

9

Case series of cetuximab monotherapy for patients with pre-treated colorectal cancer complicated with hyperbilirubinemia due to severe liver metastasis.

Shitara K, Takahari D, Yokota T, Shibata T, Ura T, Muro K, Inaba Y, Yamaura H, Sato Y, Najima M, Utsunomiya S. Shitara K, et al. Among authors: muro k. Jpn J Clin Oncol. 2010 Mar;40(3):275-7. doi: 10.1093/jjco/hyp161. Epub 2009 Nov 28. Jpn J Clin Oncol. 2010. PMID: 19946122 No abstract available.

10

Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS.

Shitara K, Yokota T, Takahari D, Shibata T, Ura T, Utsunomiya S, Inaba Y, Yamaura H, Sato Y, Najima M, Kawai H, Tajika M, Sawaki A, Yatabe Y, Muro K. Shitara K, et al. Among authors: muro k. Invest New Drugs. 2011 Aug;29(4):688-93. doi: 10.1007/s10637-009-9382-x. Epub 2010 Jan 14. Invest New Drugs. 2011. PMID: 20072801 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters